Real-world effectiveness of first-line immunotherapy with or without chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer.

Similarly, use of proton pump inhibitors was associated with a numerically shorter OS than non−use, but the difference also did not reach statistical significance (median OS: 25.0 months vs. 17.0 months, p = 0.097) ( Figure 3B ).

also in 111,027 other papers

Patients who received antibiotics showed a trend toward shorter overall survival compared with those who did not ( Figure 3A ); however, the difference was not statistically significant (median OS: 24.5 months vs. 17.0 months, p = 0.2).

also in 53,322 other papers